Monday - November 25, 2024
Roswell Park Comprehensive Cancer Center: Breakthrough Clinical Trial Reveals Better Treatment for Advanced Classic Hodgkin Lymphoma
October 17, 2024
BUFFALO, New York, Oct. 17 (TNSres) -- The Roswell Park Comprehensive Cancer Center issued the following news release on Oct. 16, 2024:

* * *

Roswell Park's Dr. Kara Kelly co-developed study that could speed younger patients' access to this therapy

Highlights

* Nivolumab (Opdivo) superior to brentuximab vedotin (Adcetris) in combination

* Clinical trial results expected to change the standard of care

* Study published . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products